CLINICAL_TRIALS
trial_result
· 2019-02-22
Clinical Trial Update: Safety and Efficacy of Wendan Decoction in Acute Moderated to Severe Brain Injury [Phase 2, Phase 3]
Summary
Phase 2 and Phase 3 results evaluating the safety and efficacy of Wendan Decoction for acute brain injury (moderate to severe) are reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taichung Tzu Chi Hospital | Conditions: Acute Brain Injury | Phase 2, Phase 3 | Status: COMPLETED